Jaguar Health Inc (JAGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -39,034 | -41,870 | -49,075 | -52,600 | -33,809 |
| Depreciation Amortization | 2,632 | 15,594 | 14,050 | 6,984 | 4,950 |
| Accounts receivable | 526 | 298 | -421 | 2,416 | -2,866 |
| Accounts payable and accrued liabilities | 328 | -855 | 902 | 158 | -743 |
| Other Working Capital | -3,010 | -11,099 | -4,428 | 2,267 | -3,467 |
| Other Operating Activity | 9,174 | 4,690 | 5,868 | 5,805 | 20,657 |
| Operating Cash Flow | $-29,384 | $-33,242 | $-33,104 | $-34,970 | $-15,278 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -16 | N/A | -77 | -6 | -7 |
| Purchase Sale Intangibles | -215 | N/A | -1,598 | N/A | N/A |
| Other Investing Activity | -215 | 0 | -1,598 | 0 | 0 |
| Investing Cash Flow | $-231 | $N/A | $-1,675 | $-6 | $-7 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | 3,975 | 10,975 | 12,300 |
| Common Stock Issued | 31,910 | 33,336 | 20,462 | 35,615 | 7,756 |
| Other Financing Activity | -708 | 891 | -1,256 | -2,653 | -564 |
| Financing Cash Flow | $31,202 | $34,227 | $23,181 | $43,937 | $19,492 |
| Exchange Rate Effect | -54 | 15 | 16 | 0 | N/A |
| Beginning Cash Position | 6,469 | 5,469 | 17,051 | 8,090 | 3,883 |
| End Cash Position | 8,002 | 6,469 | 5,469 | 17,051 | 8,090 |
| Net Cash Flow | $1,533 | $1,000 | $-11,582 | $8,961 | $4,207 |
| Free Cash Flow | |||||
| Operating Cash Flow | -29,384 | -33,242 | -33,104 | -34,970 | -15,278 |
| Capital Expenditure | -16 | N/A | -77 | -6 | -7 |
| Free Cash Flow | -29,400 | -33,242 | -33,181 | -34,976 | -15,285 |